Orum Therapeutics, Inc. (KOSDAQ:475830)
120,000
+5,800 (5.08%)
Dec 30, 2025, 3:30 PM KST
| Market Cap | 2.54T |
| Revenue (ttm) | 25.48M |
| Net Income (ttm) | -36.88B |
| Shares Out | 21.16M |
| EPS (ttm) | -2,048.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 358,469 |
| Average Volume | 550,306 |
| Open | 112,400 |
| Previous Close | 114,200 |
| Day's Range | 111,700 - 120,800 |
| 52-Week Range | 15,950 - 120,700 |
| Beta | n/a |
| RSI | 77.07 |
| Earnings Date | Mar 20, 2026 |